These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 22217943)

  • 21. Augmentation of clozapine with amisulpride: a promising therapeutic approach to refractory schizophrenic symptoms.
    Kämpf P; Agelink MW; Naber D
    Pharmacopsychiatry; 2005 Jan; 38(1):39-40. PubMed ID: 15706467
    [No Abstract]   [Full Text] [Related]  

  • 22. Clozapine and lithium require Caenorhabditis elegans β-arrestin and serum- and glucocorticoid-inducible kinase to affect Daf-16 (FOXO) localization.
    Weeks KR; Dwyer DS; Aamodt EJ
    J Neurosci Res; 2011 Oct; 89(10):1658-65. PubMed ID: 21732403
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Bipolar disorder.
    Belmaker RH
    N Engl J Med; 2004 Jul; 351(5):476-86. PubMed ID: 15282355
    [No Abstract]   [Full Text] [Related]  

  • 24. Augmentation of clozapine with valproic Acid for clozapine-induced obsessive-compulsive symptoms.
    Zink M; Englisch S; Knopf U; Kuwilsky A; Dressing H
    Pharmacopsychiatry; 2007 Sep; 40(5):202-3. PubMed ID: 17874353
    [No Abstract]   [Full Text] [Related]  

  • 25. Effectiveness of amisulpride augmentation of clozapine in a non-responder to either drug alone: a case report.
    George S; Cowan C
    Acta Psychiatr Scand; 2005 Feb; 111(2):163. PubMed ID: 15667440
    [No Abstract]   [Full Text] [Related]  

  • 26. Comedication of Valproic Acid Is Associated With Increased Metabolism of Clozapine.
    Hommers L; Scharl M; Hefner G; Hohner M; Fischer M; Pfuhlmann B; Deckert J; Unterecker S
    J Clin Psychopharmacol; 2018 Jun; 38(3):188-192. PubMed ID: 29620699
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pregabalin in the treatment of schizophrenic anxiety.
    Schönfeldt-Lecuona C; Wolf RC; Osterfeld ND; Vasic N; Connemann BJ; Schmid M; Freudenmann RW
    Pharmacopsychiatry; 2009 May; 42(3):124-5. PubMed ID: 19452382
    [No Abstract]   [Full Text] [Related]  

  • 28. [New psychopharmacologic alternatives in treatment of schizophrenia].
    Bryois C
    Schweiz Arch Neurol Psychiatr (1985); 1994; 145(6):19-24. PubMed ID: 7533941
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical predictors of serum clozapine levels in patients with treatment-resistant schizophrenia.
    Rajkumar AP; Poonkuzhali B; Kuruvilla A; Jacob M; Jacob KS
    Int Clin Psychopharmacol; 2013 Jan; 28(1):50-6. PubMed ID: 23104241
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Adjunctive ondansetron in schizophrenia--A pilot study.
    Hema T; Maran S; Subhashini G
    Asian J Psychiatr; 2016 Feb; 19():66-7. PubMed ID: 26957341
    [No Abstract]   [Full Text] [Related]  

  • 31. [Clozapine in treatment of neuropsychiatric diseases in the elderly].
    Retz W; Rösler M; Sitzmann L; Becker T
    Fortschr Neurol Psychiatr; 1997 Aug; 65(8):347-53. PubMed ID: 9378447
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Blood biogenic amines during clozapine treatment of early-onset schizophrenia.
    Schulz E; Fleischhaker C; Clement HW; Remschmidt H
    J Neural Transm (Vienna); 1997; 104(10):1077-89. PubMed ID: 9503259
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Alterations of glucose metabolism during treatment with clozapine or amisulpride: results from a prospective 16-week study.
    Rettenbacher MA; Hummer M; Hofer A; Baumgartner S; Ebenbichler C; Edlinger M; Kemmler G; Lechleitner M; Wolfgang Fleischhacker W
    J Psychopharmacol; 2007 Jun; 21(4):400-4. PubMed ID: 17050656
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparison of the bioequivalence of generic versus branded clozapine.
    Ereshefsky L; Glazer WM
    J Clin Psychiatry; 2001; 62 Suppl 5():25-7. PubMed ID: 11305845
    [No Abstract]   [Full Text] [Related]  

  • 35. Tardive dystonia induced by switch of atypical antipsychotics.
    Chen CC; Chen YY; Hung GC
    Pharmacopsychiatry; 2010 Jul; 43(5):200-1. PubMed ID: 20486043
    [No Abstract]   [Full Text] [Related]  

  • 36. New developments in the pharmacological treatment of schizophrenia.
    Kane JM
    Bull Menninger Clin; 1992; 56(1):62-75. PubMed ID: 1348197
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Amisulpride monotherapy in a patient with clozapine-resistant schizophrenia.
    Pehlivanidis A; Spyropoulou AC; Tourkantonis A; Papadimitriou GN
    Clin Neuropharmacol; 2010 May; 33(3):168. PubMed ID: 20502137
    [No Abstract]   [Full Text] [Related]  

  • 38. Seizure on low-dose clozapine.
    Ravasia S; Dickson RA
    Can J Psychiatry; 1998 May; 43(4):420. PubMed ID: 9598281
    [No Abstract]   [Full Text] [Related]  

  • 39. Clozapine-Associated Kidney Injury Complicated by Lithium Toxicity: A Case Report and Literature Review.
    DeLucia B
    J Clin Psychopharmacol; 2019; 39(3):273-275. PubMed ID: 30939593
    [No Abstract]   [Full Text] [Related]  

  • 40. Combined use of amisulpride and clozapine for patients with treatment-resistant schizophrenia.
    Cook B; Hoogenboom G
    Australas Psychiatry; 2004 Mar; 12(1):74-6. PubMed ID: 15715745
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.